Author

Lisa Devereux

The University of MelbourneORCID 0000-0003-2435-5888Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Gregory Bruce ManniD· 2 shared Ian G CampbelliD· 2 shared Sunil R. LakhaniiD· 2 shared Amanda B. SpurdleiD· 1 shared Amy E. McCart ReediD· 1 shared Andrew R. GreeniD· 1 shared Anita Rohini SkandarajahiD· 1 shared Cristina FortuñoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gregory Bruce MannORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyThe Journal of PathologyPeer-reviewedOct 30, 2025

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

Tanjina Kader, Maia Zethoven, Sakshi Mahale…·Kylie L. Gorringe

The paper analyzes paired breast carcinomas to determine if recurrences are clonal or new tumors, finding 7% are non-clonal by whole exome sequencing.

2 citations

humanwhole-exome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintJun 12, 2025

Integrating breast tumor homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification

Cristina Fortuño, Jia Zhang, Lambros T. Koufariotis…·Nicola Waddell

This paper integrates tumor homologous recombination deficiency status with germline BRCA1 and BRCA2 variant classification to improve pathogenicity prediction.

DOI 10.1101/2025.06.12.25329237

humanwhole-genome sequencing

𝕏 PostBluesky